Skip to content

Citius Oncology, Inc.

CTOR· NasdaqCore metricsCIK 1851484

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -2.88%
Market cap
$50.23M
92.98M shares
Filings
280
$1.49M
Q3 2026
—
-$8.92M
Q3 2026N/M FY25 yoy
-$8.72M
Q3 2026N/M FY25 yoy
—
—
—
-$0.08
Q3 2026N/M FY25 yoy
$16.56M
Q3 2026+3,504,282.1% FY25 yoy
$50.23M
—
—
1.2×
—
—

FY2025 figures · derived

Price

$0.540260.42%$0.8248past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.49MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Citius Oncology, Inc. is the 335th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Citius Oncology, Inc. · CIK 1851484 · Engraved from SEC EDGAR